Safety Evaluation of Curecode Soothing Relief Gel for Primary Skin Irritation in Humans

Skin Irritation Test of "Curecode Soothing Relief Gel"

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011682

Enrollment

Registered

2026-03-05

Start date

2024-12-09

Completion date

Unknown

Last updated

2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Cosmetic product) : The test products, including “Curecode Soothing Relief Gel and five additional products,” were applied to the backs of healthy adult subjects using a 24-hour occlusive patch

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Healthy male and female adults aged 20 to 60 years. 2. Individuals with no visible skin disease or damage on the test site (back). 3. Subjects who voluntarily provided written informed consent after receiving a full explanation of the study. 4. Subjects who were able to comply with study procedures and visit schedules.

Exclusion criteria

Exclusion criteria: 1. Subjects with current or history of skin diseases, inflammation, or hypersensitivity at the test site. 2. Individuals who received dermatological treatment within the past 1 month. 3. Subjects currently using systemic or topical steroids or immunosuppressive agents. 4. Pregnant or breastfeeding women. 5. Individuals deemed unsuitable for participation by the investigator.

Design outcomes

Primary

Measure	Time frame
Mean skin reaction score after a 24-hour occlusive patch test	—

Secondary

Measure	Time frame
Incidence of adverse reactions and distribution of irritation grades	—

Countries

Korea, Republic of

Contacts

Public ContactMinyoul Chang

SKINMED

mychang195@gmail.com+82-42-5118-8437

Outcome results